AHA Center for Health Innovation

Health care’s thought leaders, innovators and doers recently convened at the AHA Leadership Summit in San Diego. They explored innovation processes and transformational strategies to better engage patients, and deliver greater value through operational excellence and new care delivery models. Learn…
Often quietly and out of the public eye, the vital work of advancing health in America happens on many fronts.
Health care’s leading thinkers, innovators and doers recently convened at the AHA Leadership Summit in San Diego. They explored innovation processes and transformational strategies to better engage patients. Look inside for what had health care leaders buzzing at the conference.
What do New York-Presbyterian, Henry Ford Health System of Detroit, and Children’s Hospital Los Angeles all have in common?  
At the Summit’s inaugural Startup Competition, attendees met and judged six finalist teams chosen for their practical and tactical solutions from applications submitted by more than 50 organizations. Members of each team discussed the problem they were trying to solve, how their solution worked and…
It’s getting tougher to find a retail pharmacy chain that isn’t expanding deeper into providing web-driven digital health care services. Rite Aid became the latest, saying it will launch telehealth kiosks with InTouch Health’s virtual care platform at 25 of Rite Aid’s East Coast RediClinic Express…
Writing recently in the research journal Nature, two experts from Northwestern University’s bio-integrated electronics department and the director of a Chicago based research lab, noted that millions of early versions of sensors, computers and transmitters woven into flexible films, patches,…
In a move that eventually could disrupt the dialysis market, CVS Health recently began a trial for its HemoCare device to determine whether it is more convenient and effective than clinic-based treatment. HemoCare uses an artificial kidney device to simplify dialysis for home-based patients.
Google’s DeepMind, the artificial intelligence arm of Alphabet Inc., has shown promise in predicting the shapes of proteins, the building blocks of disease. A recent Bloomberg report notes that this could lead to more rapid development of drugs.